Published in J Toxicol Clin Toxicol on January 01, 2001
The safety and efficacy of antivenin Latrodectus mactans. J Toxicol Clin Toxicol (2001) 0.94
Molecular evolution of α-latrotoxin, the exceptionally potent vertebrate neurotoxin in black widow spider venom. Mol Biol Evol (2013) 0.91
Treatments for Latrodectism-A Systematic Review on Their Clinical Effectiveness. Toxins (Basel) (2017) 0.75
Effect of maximal daily doses of acetaminophen on the liver of alcoholic patients: a randomized, double-blind, placebo-controlled trial. Arch Intern Med (2001) 3.55
The role of Pax-6 in eye and nasal development. Development (1995) 3.00
Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat Genet (1992) 2.71
Intravenous administration of oral N-acetylcysteine. Crit Care Med (1998) 2.46
Accelerated evolution in the reactive centre regions of serine protease inhibitors. Nature (1987) 2.40
A Y chromosome gene family with RNA-binding protein homology: candidates for the azoospermia factor AZF controlling human spermatogenesis. Cell (1993) 2.15
Pattern of serum protein gene expression in mouse visceral yolk sac and foetal liver. EMBO J (1984) 2.09
Most highly repeated dispersed DNA families in the mouse genome. Mol Cell Biol (1984) 2.04
Prevention of gastrointestinal iron absorption by chelation from an orally administered premixed deferoxamine/charcoal slurry. Ann Emerg Med (1997) 2.03
Regulation of major acute-phase plasma proteins by hepatocyte-stimulating factors of human squamous carcinoma cells. J Cell Biol (1986) 1.96
The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients--a multicenter randomized study. BMC Med (2007) 1.69
Hox-1.6: a mouse homeo-box-containing gene member of the Hox-1 complex. EMBO J (1987) 1.61
Mammalian and Drosophila dachshund genes are related to the Ski proto-oncogene and are expressed in eye and limb. Mech Dev (1998) 1.60
The Msh-like homeobox genes define domains in the developing vertebrate eye. Development (1991) 1.54
A clue to the basic defect in cystic fibrosis from cloning the CF antigen gene. Nature (1987) 1.53
Multiple functions for Pax6 in mouse eye and nasal development. Genes Dev (1996) 1.49
Plasma protease inhibitors in mouse and man: divergence within the reactive centre regions. Nature (1984) 1.48
Tricyclic antidepressants directly depress human myocardial mechanical function independent of effects on the conduction system. Acad Emerg Med (2001) 1.48
Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic. Chem Res Toxicol (2000) 1.45
The mouse bagpipe gene controls development of axial skeleton, skull, and spleen. Proc Natl Acad Sci U S A (1999) 1.42
Research directions in emergency medicine. Am J Emerg Med (1996) 1.41
Expression of the mouse labial-like homeobox-containing genes, Hox 2.9 and Hox 1.6, during segmentation of the hindbrain. Development (1991) 1.40
Measurements of ultracold-neutron lifetimes in solid deuterium. Phys Rev Lett (2002) 1.38
Regulation of Msx-1, Msx-2, Bmp-2 and Bmp-4 during foetal and postnatal mammary gland development. Development (1996) 1.36
Primary defects in the lens underlie complex anterior segment abnormalities of the Pax6 heterozygous eye. Proc Natl Acad Sci U S A (2001) 1.36
The transcription factor, Pax6, is required for cell proliferation and differentiation in the developing cerebral cortex. Cereb Cortex (1999) 1.32
Different roles for Pax6 in the optic vesicle and facial epithelium mediate early morphogenesis of the murine eye. Development (2000) 1.27
Enzymatic methylation of arsenic compounds: assay, partial purification, and properties of arsenite methyltransferase and monomethylarsonic acid methyltransferase of rabbit liver. Chem Res Toxicol (1995) 1.26
A genetic locus closely linked to a protease inhibitor gene complex controls the level of multiple RNA transcripts. Mol Cell Biol (1985) 1.24
Disruption of PAX6 function in mice homozygous for the Pax6Sey-1Neu mutation produces abnormalities in the early development and regionalization of the diencephalon. Mech Dev (1997) 1.24
Recurrent and persistent coagulopathy following pit viper envenomation. Arch Intern Med (1999) 1.24
DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J Pharmacol Exp Ther (1997) 1.24
Molecular analysis of chromosome 11 deletions in aniridia-Wilms tumor syndrome. Proc Natl Acad Sci U S A (1985) 1.22
Determination of the migratory capacity of embryonic cortical cells lacking the transcription factor Pax-6. Development (1997) 1.21
Effects of training duration on substrate turnover and oxidation during exercise. J Appl Physiol (1985) (1996) 1.17
Isolation of two cDNAs encoding novel alpha 1-antichymotrypsin-like proteins in a murine chondrocytic cell line. Gene (1991) 1.16
A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med (2001) 1.15
Determination of serum tolbutamide and chlorpropamide by high-performance liquid chromatography. J Chromatogr (1978) 1.15
A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther (2007) 1.12
Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology (1995) 1.09
Segment-specific expression of a homoeobox-containing gene in the mouse hindbrain. Nature (1989) 1.09
Acute myocardial infarction associated with amphetamine use. Mayo Clin Proc (2001) 1.07
Growth response to 4-hydroxy-L-threonine of Escherichia coli mutants blocked in vitamin B6 biosynthesis. FEBS Lett (1993) 1.06
Position-dependent expression of two related homeobox genes in developing vertebrate limbs. Nature (1991) 1.04
Fecal clearance of alpha 1-antitrypsin: a reliable measure of enteric protein loss in children. J Pediatr (1981) 1.04
The toxicity of cyanobacterial toxins in the mouse: I microcystin-LR. Hum Exp Toxicol (1999) 1.03
Human homologs of a Drosophila Enhancer of split gene product define a novel family of nuclear proteins. Nat Genet (1992) 1.01
Placental transfer of N-acetylcysteine following human maternal acetaminophen toxicity. J Toxicol Clin Toxicol (1997) 1.01
Urinary mercury after administration of 2,3-dimercaptopropane-1-sulfonic acid: correlation with dental amalgam score. FASEB J (1992) 1.01
The clinical spectrum of Jin Bu Huan toxicity. Arch Intern Med (1996) 1.01
Olanzapine overdose mimicking opioid intoxication. Ann Emerg Med (1999) 1.00
The dominant hemimelia mutation uncouples epithelial-mesenchymal interactions and disrupts anterior mesenchyme formation in mouse hindlimbs. Development (1999) 0.98
Determination and metabolism of dithiol chelating agents. XVI: Pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers. J Pharmacol Exp Ther (1994) 0.98
Amniotic fluid lipase in two cases of duodenal obstruction. Am J Obstet Gynecol (1978) 0.97
The status of glycolaldehyde in the biosynthesis of vitamin B6. J Biol Chem (1980) 0.97
Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans. J Pharmacol Exp Ther (1991) 0.97
Urinary excretion of meso-2,3-dimercaptosuccinic acid in human subjects. Clin Pharmacol Ther (1989) 0.97
Expression of the chicken homeobox-containing gene GHox-8 during embryonic chick limb development. Mech Dev (1991) 0.97
Antagonistic effects of FGF4 on BMP induction of apoptosis and chondrogenesis in the chick limb bud. Mech Dev (1998) 0.96
Human studies with the chelating agents, DMPS and DMSA. J Toxicol Clin Toxicol (1992) 0.96
DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine. Toxicol Appl Pharmacol (2000) 0.96
Recurrent coagulopathy after antivenom treatment of crotalid snakebite. South Med J (2000) 0.96
Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. Arch Intern Med (1996) 0.95
Two enhancer domains control early aspects of the complex expression pattern of Msx1. Mech Dev (1997) 0.95
Effects of retinoic acid excess on expression of Hox-2.9 and Krox-20 and on morphological segmentation in the hindbrain of mouse embryos. EMBO J (1991) 0.94
Biosynthesis of vitamin B6. Incorporation of glycolaldehyde into pyridoxal. J Chem Soc Perkin 1 (1975) 0.94
Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings. Am J Med Genet (1998) 0.93
Retention behaviour of a bonded reversed phase in a high-performance liquid chromatographic assay of serum theophylline. J Chromatogr (1977) 0.93
Colipase and maximally activated pancreatic lipase in normal subjects and patients with steatorrhea. J Clin Invest (1982) 0.93
Antivenom therapy in the Americas. Drugs (1999) 0.93
Biosynthesis of vitamin B 6 . J Biol Chem (1972) 0.92
Relationship of venom effects to venom antigen and antivenom serum concentrations in a patient with Crotalus atrox envenomation treated with a Fab antivenom. Ann Emerg Med (1997) 0.92
The regiochemistry and stereochemistry of the biosynthesis of vitamin B6 from triose units. J Biol Chem (1987) 0.92
The murine Spi-2 proteinase inhibitor locus: a multigene family with a hypervariable reactive site domain. EMBO J (1991) 0.92
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. Urinary mercury, porphyrins and neurobehavioral changes of dental workers in Monterrey, Mexico. J Pharmacol Exp Ther (1995) 0.91
Fumaric aciduria: a new organic aciduria, associated with mental retardation and speech impairment. Clin Chim Acta (1983) 0.91
Smith-Lemli-Opitz syndrome: a treatable inherited error of metabolism causing mental retardation. CMAJ (1999) 0.90
Effects of insulin on messenger RNA activities in rat liver. J Biol Chem (1981) 0.90
Experimental analysis of the control of expression of the homeobox-gene Msx-1 in the developing limb and face. Development (1993) 0.89
Emk, a protein kinase with homologs in yeast maps to mouse chromosome 19. Mamm Genome (1993) 0.89
Steatorrhea and pancreatic insufficiency in Shwachman syndrome. Gastroenterology (1982) 0.89
Double labeling for whole-mount in situ hybridization in mouse. Biotechniques (1998) 0.88
Biosynthesis of pyridoxol. The origin of the C2-unit, C-2',-2. J Biol Chem (1981) 0.88
Effects of constriction bands on rattlesnake venom absorption: a pharmacokinetic study. Ann Emerg Med (1992) 0.87
Biosynthesis of pyridoxine. J Am Chem Soc (1971) 0.86
A single-arm clinical trial of a 48-hour intravenous N-acetylcysteine protocol for treatment of acetaminophen poisoning. Clin Toxicol (Phila) (2014) 0.86
Biosynthesis of vitamin B6. Incorporation of terminally labelled glucose. Can J Biochem (1973) 0.85
Successful treatment of latrodectism with antivenin after 90 hours. N Engl J Med (1999) 0.84
Accidental, intravenous infusion of a peanut oil-based medication. J Toxicol Clin Toxicol (1998) 0.84
DMPS (2,3-dimercaptopropane-1-sulfonate, dimaval) decreases the body burden of mercury in humans exposed to mercurous chloride. J Pharmacol Exp Ther (1998) 0.83
Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride. J Pharmacol Exp Ther (1996) 0.83
Ingestion of low-concentration hydrofluoric acid: an insidious and potentially fatal poisoning. Ann Emerg Med (1999) 0.83
The toxicity of cyanobacterial toxins in the mouse: II anatoxin-a. Hum Exp Toxicol (1999) 0.82
A selective and sensitive assay for urinary metanephrine and normetanephrine using gas chromatography mass spectrometry with selected ion monitoring. Biomed Mass Spectrom (1978) 0.82
Cloning and sequencing of the mouse Gli2 gene: localization to the Dominant hemimelia critical region. Genomics (1997) 0.82
Rethinking the toxic methanol level. J Toxicol Clin Toxicol (2003) 0.82